Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Compass Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- +18 vs. Q3 2022
- Shares held
- 79.8M
- +14.0M (+21.3%) vs. Q3 2022
- Total value
- $401.4M
- +$251.2M (+167.3%) vs. Q3 2022
- New holders
- 19
- 22 more added
- Sold out
- 1
- 5 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $363.4M |
| Q1 2026 | 201 | $921.3M |
| Q4 2025 | 173 | $881.5M |
| Q3 2025 | 125 | $535.7M |
| Q2 2025 | 103 | $281.9M |
| Q1 2025 | 108 | $206.1M |
| Q4 2024 | 92 | $147.0M |
| Q3 2024 | 79 | $169.7M |
| Q2 2024 | 82 | $93.5M |
| Q1 2024 | 78 | $187.9M |
| Q4 2023 | 77 | $134.8M |
| Q3 2023 | 76 | $176.7M |
| Q2 2023 | 73 | $287.7M |
| Q1 2023 | 73 | $285.1M |
| Q4 2022 | 55 | $401.4M |
| Q3 2022 | 38 | $153.7M |
| Q2 2022 | 34 | $163.9M |
| Q1 2022 | 34 | $85.4M |
| Q4 2021 | 37 | $201.6M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Compass Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 22,362,850 | $112.5M | 2.15% | +402,000+1.8% | Added |
| FMR LLC | 6,354,814 | $32.0M | 0.00% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 5,939,290 | $29.8M | 0.02% | −1,106,670−15.7% | Reduced |
| Adage Capital Partners GP, L.L.C. | 5,774,800 | $29.0M | 0.07% | +1,168,200+25.4% | Added |
| Rock Springs Capital Management LP | 5,333,188 | $26.8M | 0.65% | 00.0% | Unchanged |
| Blackstone Group Inc. | 4,620,998 | $23.2M | 0.09% | +3,115,260+206.9% | Added |
| Foresite Capital Management V, LLC | 4,400,000 | $22.1M | 17.19% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,610,404 | $18.2M | 0.00% | +1,229,781+51.7% | Added |
| Vivo Capital, LLC | 3,557,630 | $17.9M | 2.06% | +1,557,630+77.9% | Added |
| CHI Advisors LLC | 2,829,712 | $14.2M | 3.79% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 2,230,441 | $11.2M | 4.83% | +1,000,000+81.3% | Added |
| Avidity Partners Management LP | 2,000,000 | $10.1M | 0.24% | 00.0% | Unchanged |
| Braidwell LP | 1,814,266 | $9.13M | 0.31% | +1,814,266 | New |
| Baker Bros. Advisors LP | 1,557,630 | $7.83M | 0.05% | +1,557,630 | New |
| BlackRock Inc. | 1,237,781 | $6.23M | 0.00% | +365,284+41.9% | Added |
| Eventide Asset Management, LLC | 935,091 | $4.70M | 0.09% | −165,308−15.0% | Reduced |
| Geode Capital Management, LLC | 790,248 | $3.97M | 0.00% | +188,924+31.4% | Added |
| Fred Alger Management, LLC | 608,536 | $3.06M | 0.02% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 602,051 | $3.03M | 0.85% | +413,957+220.1% | Added |
| Alyeska Investment Group, L.P. | 545,170 | $2.73M | 0.03% | +545,170 | New |
| Susquehanna International Group, LLP | 455,681 | $2.29M | 0.00% | +435,943+2,208.6% | Added |
| Hudson Bay Capital Management LP | 311,500 | $1.49M | 0.02% | +311,500 | New |
| State Street Corp | 270,113 | $1.36M | 0.00% | +270,113 | New |
| Silverarc Capital Management, LLC | 268,307 | $1.35M | 0.46% | +6,217+2.4% | Added |
| Caxton Corp | 211,159 | $1.06M | 2.71% | +211,159 | New |
| Northern Trust Corp | 157,083 | $790.1K | 0.00% | +69,716+79.8% | Added |
| Citigroup Inc | 126,315 | $635.4K | 0.00% | +121,782+2,686.6% | Added |
| LMR Partners LLP | 124,939 | $628.4K | 0.01% | +24,939+24.9% | Added |
| Millennium Management LLC | 81,947 | $412.0K | 0.00% | +18,760+29.7% | Added |
| Morgan Stanley | 64,498 | $324.4K | 0.00% | +55,626+627.0% | Added |
| Qube Research & Technologies Ltd | 62,995 | $316.9K | 0.00% | +62,995 | New |
| Jane Street Group, LLC | 62,829 | $316.0K | 0.00% | +48,564+340.4% | Added |
| Citadel Advisors LLC | 62,276 | $313.2K | 0.00% | +62,276 | New |
| Renaissance Technologies LLC | 51,900 | $261.0K | 0.00% | −12,315−19.2% | Reduced |
| Charles Schwab Investment Management Inc | 42,767 | $215.1K | 0.00% | +11,031+34.8% | Added |
| Bank of New York Mellon Corp | 39,306 | $197.7K | 0.00% | +15,055+62.1% | Added |
| 683 Capital Management, LLC | 38,039 | $191.3K | 0.02% | +38,039 | New |
| Mirabella Financial Services LLP | 30,444 | $153.1K | 0.01% | +30,444 | New |
| Salem Investment Counselors Inc | 30,000 | $150.9K | 0.01% | 00.0% | Unchanged |
| Jump Financial, LLC | 29,200 | $146.9K | 0.01% | +29,200 | New |
| Balyasny Asset Management LLC | 28,793 | $144.8K | 0.00% | +28,793 | New |
| Marshall Wace, LLP | 28,296 | $142.3K | 0.00% | −23,520−45.4% | Reduced |
| Man Group plc | 25,305 | $127.3K | 0.00% | +25,305 | New |
| New Capital Management LP | 24,243 | $121.9K | 0.05% | 00.0% | Unchanged |
| Barclays PLC | 18,225 | $91.7K | 0.00% | +17,851+4,773.0% | Added |
| Boothbay Fund Management, LLC | 17,130 | $86.2K | 0.00% | +17,130 | New |
| National Asset Management, Inc. | 14,918 | $75.0K | 0.00% | +14,918 | New |
| Lighthouse Investment Partners, LLC | 14,662 | $73.8K | 0.01% | +14,662 | New |
| UBS Group AG | 11,819 | $59.5K | 0.00% | +4,591+63.5% | Added |
| Flagship Harbor Advisors, LLC | 11,500 | $57.8K | 0.01% | −2,500−17.9% | Reduced |
| Cubist Systematic Strategies, LLC | 10,300 | $51.8K | 0.00% | +10,300 | New |
| Tower Research Capital LLC (TRC) | 1,160 | $6.00K | 0.00% | +1,160 | New |
| Wells Fargo & Company | 636 | $3.20K | 0.00% | +179+39.2% | Added |
| Advisor Group Holdings, Inc. | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 82 | $412 | 0.00% | +82 | New |
| Royal Bank of Canada | 0 | $0 | 0.00% | −675−100.0% | Sold out |
| Foresite Capital Opportunity Management V, LLC | – | – | – | – | Not filed |